Last updated: February 25, 2025
Sponsor: Philips Clinical & Medical Affairs Global
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Attack (Myocardial Infarction)
Cardiac Disease
Treatment
HeartStart FRX
Clinical Study ID
NCT04250857
MATC-ECR-Registry-2018-10295
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects accepted into the study must: have been suspected of a circulatory arrestfor any cause
Have had HeartStart FRx AED with electrodes: HeartStart SMART PADS II applied totheir body and powered up, regardless of whether a defibrillation shock wasdelivered
Exclusion
Exclusion Criteria:
AED or pad use other than the HeartStart FRx AED with electrodes : HeartStart SMARTPADS II
AED used for training purposes.
Study Design
Total Participants: 1400
Treatment Group(s): 1
Primary Treatment: HeartStart FRX
Phase:
Study Start date:
November 04, 2019
Estimated Completion Date:
December 31, 2027
Connect with a study center
Philips
Monroeville, Pennsylvania 15146
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.